Tadafumi Yokoyama, Natsumi Inoue, Ikue Hata, Noritaka Oyama, Naotoshi Sugimoto, Taizo Wada. Anifrolumab in ARF1-related disorder: A case report of clinical response and review of its use in type I interferonopathies. // Clinical Immunology Communications. – DOI: 10.1016/j.clicom.2026.05.004. – URL: https://www.sciencedirect.com/science/article/pii/S277261342600017X?dgcid=rss_sd_all
Tadafumi Yokoyama, Natsumi Inoue, Ikue Hata, Noritaka Oyama, Naotoshi Sugimoto, & Taizo Wada Anifrolumab in ARF1-related disorder: A case report of clinical response and review of its use in type I interferonopathies. Clinical Immunology Communications. https://doi.org/10.1016/j.clicom.2026.05.004
Tadafumi Yokoyama, et al. “Anifrolumab in ARF1-related disorder: A case report of clinical response and review of its use in type I interferonopathies.” Clinical Immunology Communications. doi:10.1016/j.clicom.2026.05.004.
@article{Yokoyama,
title = {Anifrolumab in ARF1-related disorder: A case report of clinical response and review of its use in type I interferonopathies},
author = {Yokoyama, Tadafumi and Inoue, Natsumi and Hata, Ikue and Oyama, Noritaka and Sugimoto, Naotoshi and Wada, Taizo},
journal = {Clinical Immunology Communications},
doi = {10.1016/j.clicom.2026.05.004},
url = {https://www.sciencedirect.com/science/article/pii/S277261342600017X?dgcid=rss_sd_all}
}